Biocon Biologics India Limited — Ras Exporter Profile
Indian Pharmaceutical Exporter · #5 for Ras · $3.2M export value · DGFT Verified
Biocon Biologics India Limited is the #5 Indian exporter of Ras with $3.2M in export value and 64 verified shipments. Biocon Biologics India Limited holds a 1.0% market share in Ras exports across 17 countries. The company exports 5 pharmaceutical products worth $7.8M across 4 therapeutic categories.
Biocon Biologics India Limited — Ras Export Profile: Buyers & Destinations
Where Does Biocon Biologics India Limited Export Ras?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.0M | 22 | 35.4% |
| PHILIPPINES | $450.0K | 9 | 15.9% |
| UNITED STATES OF AMERICA | $400.0K | 8 | 14.2% |
| SRI LANKA | $224.3K | 6 | 7.9% |
| VIETNAM | $200.0K | 4 | 7.1% |
| NETHERLANDS | $88.5K | 2 | 3.1% |
| MALAYSIA | $50.0K | 2 | 1.8% |
| SAUDI ARABIA | $50.0K | 2 | 1.8% |
| BRAZIL | $50.0K | 1 | 1.8% |
| TAIWAN | $50.0K | 1 | 1.8% |
Biocon Biologics India Limited exports Ras to 19 countries. The largest destination is UNITED STATES accounting for 35.4% of Biocon Biologics India Limited's Ras shipments, followed by PHILIPPINES (15.9%) and UNITED STATES OF AMERICA (14.2%). These destinations reflect Biocon Biologics India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ras from Biocon Biologics India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXOSIXXLARXXNEWXX LIXXTED | UNITED STATES OF AMERICA | $1.5M | 30 |
| BIOCON BIOLOGICS UK LIMITED | BRAZIL | $688.5K | 15 |
| RV HEALTH CARE PTE LTD | VIETNAM | $200.0K | 4 |
| MEDMART PHARMA (PVT) LTD | SRI LANKA | $174.3K | 5 |
| XXOCOXXBIOXXGICXXUK XXMITXX | IRELAND | $154.8K | 4 |
| XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX | SAUDI ARABIA | $50.0K | 2 |
| BANK OF CEYLON CORPORATE BRANCH | SRI LANKA | $50.0K | 1 |
| GETZ PHARMA PVT LTD | PAKISTAN | $50.0K | 1 |
| BIOCON BIOLOGICS INC | UNITED STATES | $13 | 2 |
| XXMOSXXHARXX SEXXICEXX S X | SPAIN | $7 | 1 |
Biocon Biologics India Limited supplies Ras to 14 buyers globally. The largest buyer is XXOSIXXLARXXNEWXX LIXXTED (UNITED STATES OF AMERICA), followed by BIOCON BIOLOGICS UK LIMITED (BRAZIL) and RV HEALTH CARE PTE LTD (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ras Export Value and How Much Does Biocon Biologics India Limited Contribute?
India exported $123.4M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. Biocon Biologics India Limited contributes $3.2M to this total, accounting for 1.0% of India's Ras exports. Biocon Biologics India Limited ships Ras to 19 countries through 14 buyers.
What Is the Average Shipment Value for Biocon Biologics India Limited's Ras Exports?
Biocon Biologics India Limited's average Ras shipment value is $50.0K per consignment, based on 64 shipments totaling $3.2M. The largest destination is UNITED STATES (35.4% of Biocon Biologics India Limited's Ras exports).
How Does Biocon Biologics India Limited Compare to Other Indian Ras Exporters?
Biocon Biologics India Limited ranks #5 among 1156 Indian Ras exporters with a 1.0% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($36.5M), MSN LABORATORIES PRIVATE LIMITED ($22.3M), MYLAN LABORATORIES LIMITED ($20.1M). Biocon Biologics India Limited processed 64 shipments to 17 destination countries.
What Ras Formulations Does Biocon Biologics India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FULPHILA PEGFILGRASTIM-JMDB | $600.0K | 12 |
| TRASTUZUMAB FOR INJECTION | $358.3K | 9 |
| FULPHILA (PEGFILGRASTIM-JMDB) | $300.0K | 6 |
| OGIVRI 420 TRASTUZUMAB | $150.0K | 3 |
| OGIVRI TM 440 -TRASTUZUMAB | $100.0K | 2 |
| FULPHILA PEGFILGRASTIM- | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTION RDNA | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTIONRDNA | $100.0K | 2 |
| TRASTUZUMAB FOR INJECTION(RDNA | $100.0K | 2 |
| FULPHILA (PEGFILGRASTIM- | $100.0K | 2 |
Biocon Biologics India Limited exports 30 distinct Ras formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FULPHILA PEGFILGRASTIM-JMDB with 12 shipments worth $600.0K.
Regulatory Requirements: Exporting Ras to Key Markets
What Biocon Biologics India Limited must comply with to export Ras to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Biocon Biologics India Limited Compare to Nearest Ras Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | USV PRIVATE LIMITED | $4.9M | 98 | 9 | $50.0K |
| 13 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $4.5M | 91 | 1 | $50.0K |
| 5 | BIOCON BIOLOGICS INDIA LIMITED ★ | $3.2M | 64 | 17 | $50.0K |
| 12 | MACLEODS PHARMACEUTICALS LTD | $3.2M | 64 | 9 | $50.0K |
| 11 | INTAS PHARMACEUTICALS LTD | $2.5M | 51 | 8 | $50.0K |
Biocon Biologics India Limited ranks #5 among 1156 Indian Ras exporters. Average shipment value of $50.0K compared to the market average of $106.8K. The closest competitors by value are USV PRIVATE LIMITED and AMNEAL PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Ras Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,417 | 9.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,335 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 947 | 6.3% |
| SAHAR AIR | 935 | 6.2% |
| DELHI AIR | 709 | 4.7% |
| Bombay Air | 648 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 528 | 3.5% |
| TUTICORIN SEA (INTUT1) | 406 | 2.7% |
About Biocon Biologics India Limited
Biocon Biologics India Limited exports 5 products worth $7.8M. Beyond Ras, top products include Bevacizumab, Trastuzumab, Insulin, Ustekinumab. View the complete Biocon Biologics India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Biocon Biologics India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 70 individual customs records matching Biocon Biologics India Limited exporting Ras, covering 30 formulations to 19 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ras Export Data from Biocon Biologics India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biocon Biologics India Limited's Ras exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biocon Biologics India Limited
Full Company Profile →
5 products · $7.8M total trade · 4 categories
Ras Stats
Company Overview
Top Products by Biocon Biologics India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Biocon Biologics India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current shipment-level data, contact TransData Nexus.